ACMJ

Anatolian Current Medical Journal (ACMJ) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Araştırma Makalesi
Oruç tutan diyabet hastalarının oruç esnasında gelişen istenmeyen olaylarına geriye dönük bakış*
Aim: Type 2 diabetes prevalence continues to increase and the disease is still healthcare problem. Fasting, which is a part of daily life, is demanded by diabetics and the opinion of the physician is requested. In this study, it was aimed to investigate the frequency of adverse events experienced of diabetic patients by fasting. Material and Method: After 2018 Ramadan, 30 patients that were admit to Kırıkkale University Medical Faculty Internal Diseases outpatient clinic were evaluated. Hypoglycemia, symptoms of hypoglycemia, presyncope, syncope, dehydration, hypotension, severe weight loss, or any symptoms they described were questioned. Hospital or emergency room applications were questioned. Patients’ ages and HbA1c levels were examined. Before Ramadan, they were asked whether they received a doctor’s opinion. Findings: Median age was 53, median HbA1c was 7.3%. Eleven male and 19 female patients were evaluated. Two patients had hypoglycemia and one had hypoglycemia symptoms. No other adverse events were observed. It was learned that the patients who had hypoglycemia continued their old treatment without taking the physician’s opinion. Conclusion: It is useful to determine the risk group of diabetic patients who want to fast, and to follow up closely about the appropriate individual therapies for avoiding any adverse events.


1. Beshyah SA. Fasting during the month of Ramadan for people with diabetes: Medicine and fiqh united at last. IJMBS 2009; 1: 58–60.
2. Ghani F. Most Muslims say they fast during Ramadan. 2013.
3. Al-Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for management of diabetes during Ramadan: update 2010.
4. Ghouri N, Hussain S, Mohammed R, et al. BMJ Open Diabetes Res Care 2018; 6: e000520.
5. El Toony LF, Hamad DA, Omar OM . Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2018; 12: 761-7.
6. Bashir M, Elhadd T, Ali H, et al. A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan. Diabetes Metab Syndr 2018; 12: 965-8.
7. Bashier A, Khalifa AA, Abdelgadir EI, et al. Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2-I) during the month of Ramadan in Muslim patients with type 2 diabetes. Oman Med J 2018; 33: 104-10.
8. Shao Y , Lim GJ, Chua CL, et al. The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitör use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes. Diabetes Res Clin Pract 2018; 142: 85-91.
9. Mohan V , Kalra S, Kesavadev J. Consensus on initiation and intensification of premix insulin in type 2 diabetes management. J Assoc Physicians India 2017; 65: 59-73.
Volume 1, Issue 2, 2019
Page : 20-22
_Footer